Generali Asset Management’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.61M Buy
17,105
+2,332
+16% +$233K 0.03% 333
2025
Q4
$1.46M Sell
14,773
-9,881
-40% -$956K 0.03% 359
2025
Q3
$2.09M Sell
24,654
-6,280
-20% -$496K 0.04% 300
2025
Q2
$2.11M Buy
30,934
+14,943
+93% +$947K 0.05% 297
2025
Q1
$968K Sell
15,991
-22,496
-58% -$1.57M 0.02% 388
2024
Q4
$2.66M Buy
+38,487
New +$2.74M 0.07% 278

Other funds holding INCY

Generali Asset Management's INCY Position: Q1 2026 in Review

Generali Asset Management increased its Incyte (INCY) stake by 16% in Q1 2026, buying an estimated $233K and bringing the position to 17,105 shares worth $1.61M. The position accounts for 0.03% of the portfolio, ranked #333.

Generali Asset Management first reported a position in INCY in Q4 2024 and has held it in 6 quarters since. The position peaked at $2.66M in Q4 2024. 810 funds tracked by Wall St. Rank hold INCY as of Q1 2026.

  • Generali Asset Management held 17,105 shares of Incyte worth $1.61M as of Q1 2026.
  • Generali Asset Management bought 2,332 Incyte shares in Q1 2026, an estimated $233K.
  • Incyte made up 0.03% of Generali Asset Management's portfolio in Q1 2026, its #333 holding.
  • Generali Asset Management first reported a position in Incyte in Q4 2024 and has held it in 6 quarters since.
  • Generali Asset Management's Incyte position peaked at $2.66M in Q4 2024.
  • 810 funds tracked by Wall St. Rank held Incyte as of Q1 2026.

Based on Generali Asset Management's 13F filing for Q1 2026, filed 5 May 2026.